Skip to main content
. 2021 Aug 4;16(8):e0254347. doi: 10.1371/journal.pone.0254347

Table 1. Characteristics of 303 Arizona CoVHORT participants with lab confirmed positive COVID-19 test, with 30 or more days of follow-up, from 28 May 2020 to 24 February 2021.

Values are n (%) unless indicated otherwise.

Characteristic Total (n = 303) PASC (n = 208) No PASC (n = 95) p-valuea
Follow-up (d), median (IQR) 61 (50, 85) 62 (53, 88) 57 (48, 80) 0.005
Age (y), mean (SD) 43.6 (16.6) 43.8 (15.8) 43.1 (18.2) 0.73
Female gender, n(%) 212 (70.0) 152 (73.1) 60 (63.2) 0.07
Race/ethnicity 0.70
Hispanic 69 (22.8) 50 (24.0) 19 (20.0)
Non-Hispanic White 205 (67.7) 139 (66.8) 69 (72.6)
Other race 19 (6.3) 14 (6.7) 5 (5.3)
Education 0.0009
Some college or less 44 (14.5) 39 (18.8) 5 (5.3)
College or more 115 (38.0) 72 (34.6) 43 (45.3)
Missing 144 (47.5) 97 (46.6) 47 (49.5)
BMI (kg/m2), mean (SD) 28.0 (7.0) 28.5 (7.3) 26.9 (6.2) 0.08
Currently smokes or vapes 40 (12.7) 27 (12.2) 13 (13.7) 0.72
Any pre-existing chronic condition b 203 (67.0) 148 (71.2) 55 (57.9) 0.02
    Seasonal allergies 127 (41.9) 97 (46.6) 30 (31.6) 0.01
    Asthma 48 (15.8) 31 (14.9) 17 (17.9) 0.51
    Hypertension 45 (14.9) 34 (16.3) 10 (10.5) 0.28
COVID-19 severityc, mean (SD) 4.6 (2.4) 5.1 (2.4) 3.4 (1.9) <0.0001

Percentages may not add to 100% due to rounding and missing data. BMI = body mass index. PASC = post-acute sequalae of COVID-19, defined as any symptom reported at ≥30 days follow-up.

a For the test of any reported symptom vs no reported symptom amongst non-missing values.

b Self-reported pre-existing chronic conditions include: Thyroid disorder, asthma, chronic obstructive pulmonary disease, valley fever, emphysema, seasonal allergies, diabetes, pre-diabetes, cancer, heart disease, high blood pressure, liver disease, kidney disease, gastrointestinal conditions, depression/anxiety, autoimmune diseases.

c Self-reported COVID-19 severity based on a scale from 1–10.